dc.relation.reference | Alter, M. J. (1997). Epidemiology of hepatitis C. Hepatology 26, 62S-65S.
An, W., Kim, J. and Roeder, R. G. (2004). Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 117, 735-48.
Baeuerle, P. A. and Baltimore, D. (1988). I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242, 540-6.
Barba, G., Harper, F., Harada, T., Kohara, M., Goulinet, S., Matsuura, Y., Eder, G., Schaff, Z., Chapman, M. J., Miyamura, T. et al. (1997). Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A 94, 1200-5.
Bernat, A., Avvakumov, N., Mymryk, J. S. and Banks, L. (2003). Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300. Oncogene 22, 7871-81.
Bernstein, B. E., Humphrey, E. L., Erlich, R. L., Schneider, R., Bouman, P., Liu, J. S., Kouzarides, T. and Schreiber, S. L. (2002). Methylation of histone H3 Lys 4 in coding regions of active genes. Proc Natl Acad Sci U S A 99, 8695-700.
Chakravarti, D., Ogryzko, V., Kao, H. Y., Nash, A., Chen, H., Nakatani, Y. and Evans, R. M. (1999). A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96, 393-403.
Chen, C. H., Sheu, J. C., Wang, J. T., Huang, G. T., Yang, P. M., Lee, H. S., Lee, C. Z. and Chen, D. S. (1994). Genotypes of hepatitis C virus in chronic liver disease in Taiwan. J Med Virol 44, 234-6.
Chen, C. M., You, L. R., Hwang, L. H. and Lee, Y. H. (1997). Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor. J Virol 71, 9417-26.
Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S. M., Schurter, B. T., Aswad, D. W. and Stallcup, M. R. (1999). Regulation of transcription by a protein methyltransferase. Science 284, 2174-7.
Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. and Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-62.
Chuikov, S., Kurash, J. K., Wilson, J. R., Xiao, B., Justin, N., Ivanov, G. S., McKinney, K., Tempst, P., Prives, C., Gamblin, S. J. et al. (2004). Regulation of p53 activity through lysine methylation. Nature 432, 353-60.
Covic, M., Hassa, P. O., Saccani, S., Buerki, C., Meier, N. I., Lombardi, C., Imhof, R., Bedford, M. T., Natoli, G. and Hottiger, M. O. (2005). Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. Embo J 24, 85-96.
Daujat, S., Zeissler, U., Waldmann, T., Happel, N. and Schneider, R. (2005). HP1 binds specifically to Lys26-methylated histone H1.4, whereas simultaneous Ser27 phosphorylation blocks HP1 binding. J Biol Chem 280, 38090-5.
Davie, J. R. and Murphy, L. C. (1990). Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription. Biochemistry 29, 4752-7.
de Lucas, S., Bartolome, J., Amaro, M. J. and Carreno, V. (2003). Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-kappaB activation. Antiviral Res 60, 117-24.
Deng, W. G., Zhu, Y. and Wu, K. K. (2003). Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation. J Biol Chem 278, 4770-7.
Di Bisceglie, A. M. (1998). Hepatitis C. Lancet 351, 351-5.
Dubourdeau, M., Miyamura, T., Matsuura, Y., Alric, L., Pipy, B. and Rousseau, D. (2002). Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation -- effect of transforming growth factor beta. J Hepatol 37, 486-92.
el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-25.
Gary, J. D. and Clarke, S. (1998). RNA and protein interactions modulated by protein arginine methylation. Prog Nucleic Acid Res Mol Biol 61, 65-131.
Ghosh, S., May, M. J. and Kopp, E. B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16, 225-60.
Gomez-Gonzalo, M., Benedicto, I., Carretero, M., Lara-Pezzi, E., Maldonado-Rodriguez, A., Moreno-Otero, R., Lai, M. M. and Lopez-Cabrera, M. (2004). Hepatitis C virus core protein regulates p300/CBP co-activation function. Possible role in the regulation of NF-AT1 transcriptional activity. Virology 328, 120-30.
Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M. and Rice, C. M. (1993). Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67, 1385-95.
Grunstein, M. (1997). Histone acetylation in chromatin structure and transcription. Nature 389, 349-52.
Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-16.
Hijikata, M., Kato, N., Ootsuyama, Y., Nakagawa, M. and Shimotohno, K. (1991). Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A 88, 5547-51.
Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. C. (1991). p53 mutations in human cancers. Science 253, 49-53.
Hsieh, T. Y., Matsumoto, M., Chou, H. C., Schneider, R., Hwang, S. B., Lee, A. S. and Lai, M. M. (1998). Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J Biol Chem 273, 17651-9.
Hsu, C. H., Chang, M. D., Tai, K. Y., Yang, Y. T., Wang, P. S., Chen, C. J., Wang, Y. H., Lee, S. C., Wu, C. W. and Juan, L. J. (2004). HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. Embo J 23, 2269-80.
Jenuwein, T. and Allis, C. D. (2001). Translating the histone code. Science 293, 1074-80.
Joo, M., Hahn, Y. S., Kwon, M., Sadikot, R. T., Blackwell, T. S. and Christman, J. W. (2005). Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta. J Virol 79, 7648-57.
Kao, C. F., Chen, S. Y., Chen, J. Y. and Wu Lee, Y. H. (2004). Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene 23, 2472-83.
Kao, J. H., Chen, P. J., Lai, M. Y., Yang, P. M., Sheu, J. C., Wang, T. H. and Chen, D. S. (1995). Genotypes of hepatitis C virus in Taiwan and the progression of liver disease. J Clin Gastroenterol 21, 233-7.
Karin, M. (1998). The NF-kappa B activation pathway: its regulation and role in inflammation and cell survival. Cancer J Sci Am 4 Suppl 1, S92-9.
Kornberg, R. D. and Lorch, Y. (1999). Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98, 285-94.
Kuzmichev, A., Jenuwein, T., Tempst, P. and Reinberg, D. (2004). Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell 14, 183-93.
Lee, D. Y., Hayes, J. J., Pruss, D. and Wolffe, A. P. (1993). A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72, 73-84.
Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-31.
Li, Y. J., Stallcup, M. R. and Lai, M. M. (2004). Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. J Virol 78, 13325-34.
Lim, S. P. and Garzino-Demo, A. (2000). The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites. J Virol 74, 1632-40.
Lin, W. J., Gary, J. D., Yang, M. C., Clarke, S. and Herschman, H. R. (1996). The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem 271, 15034-44.
Liu, Q., Tackney, C., Bhat, R. A., Prince, A. M. and Zhang, P. (1997). Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol 71, 657-62.
Lo, S. Y., Masiarz, F., Hwang, S. B., Lai, M. M. and Ou, J. H. (1995). Differential subcellular localization of hepatitis C virus core gene products. Virology 213, 455-61.
Lo, S. Y., Selby, M., Tong, M. and Ou, J. H. (1994). Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution. Virology 199, 124-31.
Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L. and Bartenschlager, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-3.
Lu, W., Lo, S. Y., Chen, M., Wu, K., Fung, Y. K. and Ou, J. H. (1999). Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology 264, 134-41.
Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F. and Richmond, T. J. (1997). Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251-60.
Marusawa, H., Hijikata, M., Chiba, T. and Shimotohno, K. (1999). Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 73, 4713-20.
Matsumoto, M., Hsieh, T. Y., Zhu, N., VanArsdale, T., Hwang, S. B., Jeng, K. S., Gorbalenya, A. E., Lo, S. Y., Ou, J. H., Ware, C. F. et al. (1997). Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol 71, 1301-9.
Moradpour, D., Englert, C., Wakita, T. and Wands, J. R. (1996). Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222, 51-63.
Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T. and Koike, K. (1998). The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4, 1065-7.
Mowen, K. A., Tang, J., Zhu, W., Schurter, B. T., Shuai, K., Herschman, H. R. and David, M. (2001). Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 104, 731-41.
Nelson, P. J., Kim, H. T., Manning, W. C., Goralski, T. J. and Krensky, A. M. (1993). Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 151, 2601-12.
Nielsen, S. J., Schneider, R., Bauer, U. M., Bannister, A. J., Morrison, A., O'Carroll, D., Firestein, R., Cleary, M., Jenuwein, T., Herrera, R. E. et al. (2001). Rb targets histone H3 methylation and HP1 to promoters. Nature 412, 561-5.
Nishioka, K., Chuikov, S., Sarma, K., Erdjument-Bromage, H., Allis, C. D., Tempst, P. and Reinberg, D. (2002). Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev 16, 479-89.
Nowak, S. J. and Corces, V. G. (2004). Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 20, 214-20.
Okamoto, S., Mukaida, N., Yasumoto, K., Rice, N., Ishikawa, Y., Horiguchi, H., Murakami, S. and Matsushima, K. (1994). The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J Biol Chem 269, 8582-9.
Otsuka, M., Kato, N., Lan, K., Yoshida, H., Kato, J., Goto, T., Shiratori, Y. and Omata, M. (2000). Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem 275, 34122-30.
Patel, D., Huang, S. M., Baglia, L. A. and McCance, D. J. (1999). The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. Embo J 18, 5061-72.
Peters, A. H., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schofer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A. et al. (2001). Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107, 323-37.
Ralston, R., Thudium, K., Berger, K., Kuo, C., Gervase, B., Hall, J., Selby, M., Kuo, G., Houghton, M. and Choo, Q. L. (1993). Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol 67, 6753-61.
Ray, R. B., Lagging, L. M., Meyer, K. and Ray, R. (1996). Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 70, 4438-43.
Ray, R. B., Steele, R., Meyer, K. and Ray, R. (1998). Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene 208, 331-6.
Robertson, B., Myers, G., Howard, C., Brettin, T., Bukh, J., Gaschen, B., Gojobori, T., Maertens, G., Mizokami, M., Nainan, O. et al. (1998). Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 143, 2493-503.
Santolini, E., Migliaccio, G. and La Monica, N. (1994). Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 68, 3631-41.
Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C., Schreiber, S. L., Mellor, J. and Kouzarides, T. (2002). Active genes are tri-methylated at K4 of histone H3. Nature 419, 407-11.
Schurter, B. T., Koh, S. S., Chen, D., Bunick, G. J., Harp, J. M., Hanson, B. L., Henschen-Edman, A., Mackay, D. R., Stallcup, M. R. and Aswad, D. W. (2001). Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. Biochemistry 40, 5747-56.
Selby, M. J., Choo, Q. L., Berger, K., Kuo, G., Glazer, E., Eckart, M., Lee, C., Chien, D., Kuo, C. and Houghton, M. (1993). Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol 74 (Pt 6), 1103-13.
Shih, C. M., Chen, C. M., Chen, S. Y. and Lee, Y. H. (1995). Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol 69, 1160-71.
Shrivastava, A., Manna, S. K., Ray, R. and Aggarwal, B. B. (1998). Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J Virol 72, 9722-8.
Somasundaram, K. and El-Deiry, W. S. (1997). Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene 14, 1047-57.
Sun, C. A., Chen, H. C., Lu, C. F., You, S. L., Mau, Y. C., Ho, M. S., Lin, S. H. and Chen, C. J. (1999). Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 59, 290-6.
Suzuki, R., Sakamoto, S., Tsutsumi, T., Rikimaru, A., Tanaka, K., Shimoike, T., Moriishi, K., Iwasaki, T., Mizumoto, K., Matsuura, Y. et al. (2005). Molecular determinants for subcellular localization of hepatitis C virus core protein. J Virol 79, 1271-81.
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Krausslich, H. G., Mizokami, M. et al. (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791-6.
Wang, H., Cao, R., Xia, L., Erdjument-Bromage, H., Borchers, C., Tempst, P. and Zhang, Y. (2001a). Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 8, 1207-17.
Wang, H., Huang, Z. Q., Xia, L., Feng, Q., Erdjument-Bromage, H., Strahl, B. D., Briggs, S. D., Allis, C. D., Wong, J., Tempst, P. et al. (2001b). Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293, 853-7.
Wu, J. S., Lee, H. F., Hsiau, H. L., Lu, H. Y., Chou, W. H., Lu, C. F., Chen, H. Y., Lee, F. N., Chen, P. Y. and Tam, K. M. (1994). Genotype distribution of hepatitis C virus infection in Taiwan. J Med Virol 44, 74-9.
Yasui, K., Wakita, T., Tsukiyama-Kohara, K., Funahashi, S. I., Ichikawa, M., Kajita, T., Moradpour, D., Wands, J. R. and Kohara, M. (1998). The native form and maturation process of hepatitis C virus core protein. J Virol 72, 6048-55.
Yoshida, H., Kato, N., Shiratori, Y., Otsuka, M., Maeda, S., Kato, J. and Omata, M. (2001). Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J Biol Chem 276, 16399-405.
Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K., Sata, M., Kohara, M. and Yoshimura, A. (2002). Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med 196, 641-53.
You, L. R., Chen, C. M. and Lee, Y. H. (1999). Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J Virol 73, 1672-81.
You, L. R., Chen, C. M., Yeh, T. S., Tsai, T. Y., Mai, R. T., Lin, C. H. and Lee, Y. H. (1999). Hepatitis C virus core protein interacts with cellular putative RNA helicase. J Virol 73, 2841-53.
Zhang, Y. and Reinberg, D. (2001). Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15, 2343-60.
Zhu, N., Khoshnan, A., Schneider, R., Matsumoto, M., Dennert, G., Ware, C. and Lai, M. M. (1998). Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 72, 3691-7.
Zignego, A. L., Macchia, D., Monti, M., Thiers, V., Mazzetti, M., Foschi, M., Maggi, E., Romagnani, S., Gentilini, P. and Brechot, C. (1992). Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 15, 382-6. | en |